• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Factors Influencing Self-Perception of Recovery from Stroke in Comparison to Objective Assessments (P1.137)
CONCLUSIONS: Among individuals with minimum post-stroke disability, patient perception of degree of global recovery is strongly influenced by degree of minor residual symptoms and minimum disability. For similar disability levels, lesser degree of recovery is perceived by individuals who are younger, are male, and are of Hispanic ethnicity.Study Supported by: NIH/NINDSDisclosure: Dr. Hodgson has nothing to disclose. Dr. Sanoff has nothing to disclose. Dr. Devereux has nothing to disclose. Dr. Feudi has nothing to disclose. Dr. Cherin has nothing to disclose. Dr. Chatfield has nothing to disclose. Dr. Conwit has nothing to ...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hodgson, T. K., Sanoff, R., Devereux, G., Feudi, S., Cherin, S., Chatfield, F., Conwit, R., Hamilton, S., Sanossian, N., Starkman, S., Saver, J. Tags: Cerebrovascular Disease and Interventional Neurology: Rehabilitation and Recovery Source Type: research

Management of Early Severe Hypertension in Acute Intracerebral Hemorrhage in Primary Stroke Centers vs. Non-Stroke Center Hospitals (P01.022)
CONCLUSIONS: Antihypertensives were initiated earlier for ICH at PSCs, however steroid utilization was no different. This suggests that routing stroke patients to PSCs may improve timeliness of antihypertensive therapy for ICH and greater education requiring avoidance of steroids is desirable even within PSCs.Disclosure: Dr. Flinders has nothing to disclose. Dr. Sanossian has received personal compensation for activities with Boehringer-Ingelheim as speaker. Dr. Starkman has received research support from the National Institutes of Health, Lundbeck, Mitsubishi, and NTI. Dr. Liebeskind has received personal compensation for...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Flinders, A., Sanossian, N., Starkman, S., Liebeskind, D., Eckstein, M., Stratton, S., Pratt, F., Hamilton, S., Olivas, E., Chatfield, F., Conwit, R., Saver, J. Tags: P01 Neurocritical Care: Clinical Neurophysiology/Therapeutics Source Type: research

Modified Rankin Scale Disability Status at Day 4 Poststroke is an Informative Predictor of Final Day 90 Outcome (P6.271)
Conclusions:In acute stroke patients, the 4d modified Rankin global disability assessment is highly informative regarding final 3 month mRS disability outcome, alone, and even more strongly in combination with baseline prognostic variables. The 4d mRS is a useful measure for imputing final patient disability outcome in clinical trials and quality improvement programs.Disclosure: Dr. Asanad has nothing to disclose. Dr. Starkman has received research support from the National Institute of Health, Stryker, Biogen IDEC, Neuravi, Genentech, Covidien, and Astra-Zeneca. Dr. Hamilton has nothing to disclose. Dr. Conwit has nothing...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Asanad, S., Starkman, S., Hamilton, S., Conwit, R., Sanossian, N., Saver, J. Tags: Cerebrovascular Disease Health Services Research Source Type: research

Episodic Aphasia After Subdural Hemorrhage Due to Cortical Spreading Depression: A Case Report (P2.124)
CONCLUSION:CSD can be difficult to detect due to its brief and focal pathology. EEG should be done to exclude seizure and MRI/MRA to exclude stroke. CSD should be considered with a focal deficit with brief episodes when all other tests are negative. Better knowledge of the pathophysiolgy of CSD and its possible manifestations may facilitate a better way to diagnose as well as treatment to prevent CSD from causing permanent damage.Disclosure: Dr. Grayson has nothing to disclose. Dr. Shah has nothing to disclose. Dr. Patel has nothing to disclose. Dr. Forteza has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Grayson, J., Shah, N., Patel, S., Forteza, A. Tags: Cerebrovascular Disease and Interventional Neurology: Behavioral, Cognitive, and Miscellaneous Source Type: research

Admission Hypomagnesemia Predicts Primary Intracerebral Hemorrhage Volume (P3.093)
CONCLUSIONS: Hypomagnesemia was associated with higher admission ICH volumes in patients with lower ICH severity. While the study was limited by small numbers, a similar relationship between magnesium and ICH volume was not detected amongst patients with more severe ICH. Future studies are needed to determine if correction improves functional outcome in any targeted group of patients with ICH.Disclosure: Dr. Shiue has nothing to disclose. Dr. Boehme has nothing to disclose. Dr. Sands has nothing to disclose. Dr. Martin-Schild has received personal compensation for activities with Genentech as a speakers bureau participant....
Source: Neurology - April 8, 2015 Category: Neurology Authors: Shiue, H., Boehme, A., Sands, K., Martin-Schild, S., Hays Shapshak, A., Lyerly, M., Gadpaille, A., Khawaja, A., Sisson, A., Alvi, M., George, A., Harrigan, M. Tags: Cerebrovascular Disease and Interventional Neurology: Intracerebral Hemorrhage Source Type: research

Prehospital Initiation of Magnesium Sulfate in Patients with Acute Intracerebral Hemorrhage (S39.003)
Conclusions: Prehospital initiation permitted start of Mg therapy within the first 45 minutes of symptom onset in over half of patients, but did not alter rates of clinical deterioration in the first hours or disability at 3 months. Study Supported by NIH-NINDS Award U01 NS 44364Disclosure: Dr. Sanossian has received personal compensation for activities with Boehringer Ingelheim Pharmaceuticals, Inc. as a speakers bureau participant. Dr. Starkman has received research support from the National Institutes of Health, Lundbeck Research USA, Inc., Mitsubishi Tanabe Pharma, and Neurobiological Technologies, Inc. Dr. Liebeskind ...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Sanossian, N., Starkman, S., Liebeskind, D., Hamilton, S., Eckstein, M., Stratton, S., Pratt, F., Conwit, R., Sung, G., Saver, J. Tags: Cerebrovascular Disease and Interventional Neurology: Intracerebral Hemorrhage Source Type: research

Clinical Reasoning: A 44-year-old woman with headache followed by sudden neurologic decline
A 44-year-old woman with a history of migraines and idiopathic intracranial hypertension presented to the emergency room with 1 day of headache and nausea. She had been otherwise healthy with no sick contacts. She was afebrile without nuchal rigidity, rash, or cardiac murmur, and her neurologic examination was normal. Migraine therapy was initiated with IV prochlorperazine, ketorolac, and magnesium. Two hours later, she developed fever (101.4°F) and confusion, continually stating, "It hurts," but unable to answer questions or follow commands despite an otherwise unremarkable examination. Noncontrast head CT demonstrate...
Source: Neurology - March 25, 2013 Category: Neurology Authors: Berkowitz, A. L., Kimchi, E. Y., Hwang, D. Y., Vaitkevicius, H., Henderson, G. V., Feske, S. K., Chou, S. H.- Y. Tags: Hydrocephalus, Stroke in young adults, Meningitis, Critical care RESIDENT AND FELLOW SECTION Source Type: research

Validation of the ICH Score in Hyperacute Intracerebral Hemorrhage (S25.004)
Conclusions: In the hyperacute setting, all patients with ICH score >=4 had poor outcome. Less than 10%of the patients with an ICH score >=2 had a good outcome.Disclosure: Dr. Bulic has nothing to disclose. Dr. Sanossian has received personal compensation for activities with Boehringer-Ingelheim Pharmaceutical Inc. Dr. Starkman has received research support from the National Institutes of Health, Lundbeck, Mitsubishi, and NTI. Dr. Liebeskind has received personal compensation for activities with Concentric Medical, Inc. and CoAxia, Inc. Dr. Villablanca has nothing to disclose. Dr. Hamilton has nothing to disclose. Dr...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Bulic, S., Sanossian, N., Starkman, S., Liebeskind, D., Villablanca, P., Hamilton, S., Conwit, R., Saver, J. Tags: Cerebrovascular Disease and Interventional Neurology: Hemorrhage, Aneurysms, and Vascular Malformations Source Type: research

Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage
Conclusions: These data support the hypothesis that magnesium exerts a clinically meaningful influence on hemostasis in patients with ICH.
Source: Neurology - August 21, 2017 Category: Neurology Authors: Liotta, E. M., Prabhakaran, S., Sangha, R. S., Bush, R. A., Long, A. E., Trevick, S. A., Potts, M. B., Jahromi, B. S., Kim, M., Manno, E. M., Sorond, F. A., Naidech, A. M., Maas, M. B. Tags: All Cerebrovascular disease/Stroke, Critical care, Intracerebral hemorrhage ARTICLE Source Type: research